APA (7th ed.) Citation

Galvan, B., Ongena, L., Bruyr, J., Fettweis, G., Lucarelli, E., Lavergne, A., . . . Dequiedt, F. (2025). Subversion of mRNA degradation pathways by EWSR1: FLI1 represents a therapeutic vulnerability in Ewing sarcoma. Nature Communications, 16, . https://doi.org/10.1038/s41467-025-61725-x

Chicago Style (17th ed.) Citation

Galvan, Bartimée, et al. "Subversion of MRNA Degradation Pathways by EWSR1: FLI1 Represents a Therapeutic Vulnerability in Ewing Sarcoma." Nature Communications 16 (2025). https://doi.org/10.1038/s41467-025-61725-x.

MLA (9th ed.) Citation

Galvan, Bartimée, et al. "Subversion of MRNA Degradation Pathways by EWSR1: FLI1 Represents a Therapeutic Vulnerability in Ewing Sarcoma." Nature Communications, vol. 16, 2025, https://doi.org/10.1038/s41467-025-61725-x.